These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4684896)

  • 1. A versatile color confrontation test for the central visual field. A comparison with quantitative perimetry.
    Frisén L
    Arch Ophthalmol; 1973 Jan; 89(1):3-9. PubMed ID: 4684896
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial analysis of changes in visual field defects, employing a new instrument, to determine the activity of diseases involving the visual pathways.
    Friedmann AI
    Ophthalmologica; 1966; 152(1):1-12. PubMed ID: 5919996
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of the relative afferent pupillary defect with monocular temporal visual field loss.
    Kosmorsky GS; Tomsak RL; Diskin DK
    J Clin Neuroophthalmol; 1992 Sep; 12(3):181-91. PubMed ID: 1401165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red square test for visual field screening. A sensitive and simple bedside test.
    Mandahl A
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):683-7. PubMed ID: 7747575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visual field defects in brain tumors].
    Rintelen F
    Ophthalmologica; 1969; 158(5):451-68. PubMed ID: 4310211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Computerized and manual perimetry in patients with severe temporal visual field defects due to suprasellar tumors].
    Pereira A; Monteiro ML
    Arq Bras Oftalmol; 2005; 68(5):587-91. PubMed ID: 16322852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The extent of visual field damage in chiasmal lesions--contribution to the selection of methods for visual field examination].
    Lesták J; Houst'ava L
    Cesk Slov Oftalmol; 1995 Jul; 51(3):171-6. PubMed ID: 7656353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of visual loss associated with pituitary macroadenomas.
    Poon A; McNeill P; Harper A; O'Day J
    Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compressive lesions of the optic nerves and chiasm. Pattern of recovery of vision following surgical treatment.
    Kayan A; Earl CJ
    Brain; 1975 Mar; 98(1):13-28. PubMed ID: 164258
    [No Abstract]   [Full Text] [Related]  

  • 10. Residual vision in cortically blind hemiphields.
    Perenin MT; Jeannerod M
    Neuropsychologia; 1975 Jan; 13(1):1-7. PubMed ID: 1109450
    [No Abstract]   [Full Text] [Related]  

  • 11. The Application of a New Maximum Color Contrast Sensitivity Test to the Early Prediction of Chiasma Damage in Cases of Pituitary Adenoma: The Pilot Study.
    Slatkeviciene G; Liutkeviciene R; Glebauskiene B; Zaliuniene D; Kriauciuniene L; Bernotas G; Tamasauskas A
    Korean J Ophthalmol; 2016 Aug; 30(4):295-301. PubMed ID: 27478357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed diagnosis of chiasmal compression.
    Pruett RC; Wepsic JG
    Am J Ophthalmol; 1973 Aug; 76(2):229-36. PubMed ID: 4725007
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuro-ophthalmological alternations in patients with pituitary adenomas and intrasellar arachnoidocele].
    Cáceres M; Márquez M; Sánchez-Ramos M
    Rev Neurol; 1998 Jun; 26(154):954-6. PubMed ID: 9658466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy of confrontation visual field test in comparison with automated perimetry.
    Johnson LN; Baloh FG
    J Natl Med Assoc; 1991 Oct; 83(10):895-8. PubMed ID: 1800764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective perimetry for glaucomatous defects in ocular hypertension.
    Armaly MF
    Arch Ophthalmol; 1972 May; 87(5):518-24. PubMed ID: 5028093
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between color vision scores and quantitative perimetry in suspected glaucoma.
    Flammer J; Drance SM
    Arch Ophthalmol; 1984 Jan; 102(1):38-9. PubMed ID: 6703964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The groningen longitudinal glaucoma study III. The predictive value of frequency-doubling perimetry and GDx nerve fibre analyser test results for the development of glaucomatous visual field loss.
    Heeg GP; Jansonius NM
    Eye (Lond); 2009 Aug; 23(8):1647-52. PubMed ID: 19011607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Field Outcome Reporting in Neurosurgery: Lessons Learned from a Prospective, Multicenter Study of Transsphenoidal Pituitary Surgery.
    Mooney MA; Herro AM; Fintelmann RE; Mayberg MR; Barkhoudarian G; Gardner PA; Prevedello DM; Chicoine MR; Kelly DF; Chandler JP; Jahnke H; White WL; Little AS
    World Neurosurg; 2018 Dec; 120():e326-e332. PubMed ID: 30144606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculokinetic perimetry compared with Humphrey visual field analysis in the detection of glaucomatous visual field loss.
    Wishart PK
    Eye (Lond); 1993; 7 ( Pt 1)():113-21. PubMed ID: 8325400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stages of improvement in visual fields after pituitary tumor resection.
    Kerrison JB; Lynn MJ; Baer CA; Newman SA; Biousse V; Newman NJ
    Am J Ophthalmol; 2000 Dec; 130(6):813-20. PubMed ID: 11124302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.